Stay updated with breaking news from Peter Maag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of CareDx, Inc (NASDAQ:CDNA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price […]
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company with the mission of engineering a new class of therapies for serious...
Royce & Associates LP raised its holdings in CareDx, Inc (NASDAQ:CDNA – Free Report) by 332.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 432,505 shares of the company’s stock after purchasing an additional 332,400 shares during the quarter. Royce & Associates LP’s […]
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), announced today its participation in the Morgan Stanley 21st Annual Global Healthcare Conference to be held...
/PRNewswire/ -- Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company...